More importantly, transferring M(IL-13) that were transduced with either miR-130a-3p mimics or miR-142-5p ASO into the CCL4-treated Ccr2−/− mice rendered much milder liver fibrosis compared with transferring the untransduced M(IL-13) cells. This evidence concerns the gene CCR2 and Hepatic fibrosis.